Table 1. Human kinin B2R binding and pharmacological activities, distribution coefficient and cell permeability values of agents used in the study.
Agents / Code name | Binding hB2R-HEK293T IC50 (nM) | Bioassay hUV IC50 (nM) | Distribution coefficient log D, n-octanol/PBS (pH 7.4) | Cellular incorporation (pmol/106 cells) | ||
---|---|---|---|---|---|---|
15 min | 4 h | 24 h | ||||
HOE 140 | 5.3 ± 1.7* | 3.8 ± 0.3* | -3.06 | 0 | 0 | 0 |
FR 173657 | 37.0 ± 1.6* | 6.0 ± 0.8* | 2.89 | 116 | 139 | 185 |
d-Tat-HOE 140 (NG68) | 5.2 ± 1.0 | 18.0 ± 4.0 | -3.02 | 5 | 14 | 21 |
Cholic-HOE 140 (NG134) | 19.0 ± 6.5 | 6.5 ± 2.5 | 0.21 | 13 | 22 | 63 |
Values are means ± s.e.m. *Data taken from ref. [34]. Binding assays were performed using living adherent HEK-293T cells transiently transfected with hB2R. Pharmacological activities of B2RAs were performed on human de-endothelized umbilical veins (hUV). Distribution coefficient of compounds between n-octanol and 0.1 M sodium phosphate buffer, pH 7.4, was determined by the shake flask methodology. Compound content of the aqueous and octanol phases was quantified by RP-HPLC. Cellular incorporation of B2RAs within MDA-MB-231 cells were assessed using a tandem quadrupole LC-MS/MS system. Results are the average of two independent assays.